Scilex Holding (SCLX) Times Interest Earned (2021 - 2026)
Scilex Holding (SCLX) recorded quarterly Times Interest Earned of -$8.51 in Q1 2026, up 73.2% quarter-over-quarter from -$31.76 in Q4 2025, and up 24.3% on a YoY basis from -$6.85 in Q1 2025.
Scilex Holding (SCLX) Times Interest Earned (2021 - 2026) Analysis & Trends
Scilex Holding's Times Interest Earned history runs 6 years deep, the most recent figure standing at -$8.51 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 24.3% year-over-year to -$8.51; the TTM figure through Mar 2026 stood at -$27.46 (down 17.02% YoY), while the FY2025 annual figure was -$30.2, up 28.93% from the prior year.
- Times Interest Earned was -$8.51 for Q1 2026 at Scilex Holding, up from -$31.76 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$4.83 in Q1 2023 to a low of -$1385.4 in Q2 2022.
- Historically, Times Interest Earned has averaged -$178.46 across 5 years, with a median of -$31.76 in 2025.
- Biggest YoY gain for Times Interest Earned was 99.59% in 2023; the steepest drop was 1223.9% in 2023.
- A 5-year view of Times Interest Earned shows it stood at -$19.58 in 2022, then sank by 69.95% to -$33.28 in 2023, then sank by 199.17% to -$99.57 in 2024, then soared by 68.11% to -$31.76 in 2025, then surged by 73.2% to -$8.51 in 2026.
- The last three Times Interest Earned figures came in at -$8.51 (Q1 2026), -$31.76 (Q4 2025), and -$66.66 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | - |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | - |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | - |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn | -8.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.51 |
| Dec 31, 2025 | -31.76 |
| Sep 30, 2025 | -66.66 |
| Jun 30, 2025 | -7.65 |
| Mar 31, 2025 | -11.24 |
| Dec 31, 2024 | -99.57 |
| Sep 30, 2024 | -34.58 |
| Jun 30, 2024 | -27.36 |
| Mar 31, 2024 | -36.68 |
| Dec 31, 2023 | -33.28 |
| Sep 30, 2023 | -75.64 |
| Jun 30, 2023 | -5.94 |
| Mar 31, 2023 | -4.83 |
| Dec 31, 2022 | -19.58 |
| Sep 30, 2022 | -5.71 |
| Jun 30, 2022 | -1,385.39 |
| Mar 31, 2022 | -1,179.48 |
| Dec 31, 2021 | -704.35 |